In October, pharmaceutical manufacturers in the Centre-Val de Loire sold cheaper while their production costs continued to rise. The companies interviewed by the Banque de France now find their cash flow insufficient.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
In October, pharmaceutical manufacturers in the Centre-Val de Loire sold cheaper while their production costs continued to rise. The companies interviewed by the Banque de France now find their cash flow insufficient.